Posted by Michael Wonder on 28 Aug 2019
Who could replace Sir Andrew Dillon at NICE?
28 August 2019 - With Sir Andrew Dillon announcing his retirement as chief executive of NICE, pharmaphorum discusses potential replacements for the man who is arguable the most influential figure in health technology assessment.
With his leadership of NICE over the last two decades, Sir Andrew Dillon has become a figure revered in the field of health technology assessment that he has helped to develop, and reviled by some in pharma.
NICE was the first organisation of its kind, pushing back against the might of big pharma and requiring companies to justify the prices charged for their novel medicines.
